368 related articles for article (PubMed ID: 35105292)
21. Epigenetics of depression.
Lolak S; Suwannarat P; Lipsky RH
Prog Mol Biol Transl Sci; 2014; 128():103-37. PubMed ID: 25410543
[TBL] [Abstract][Full Text] [Related]
22. DNA Methylation in Major Depressive Disorder.
Pishva E; Rutten BPF; van den Hove D
Adv Exp Med Biol; 2017; 978():185-196. PubMed ID: 28523547
[TBL] [Abstract][Full Text] [Related]
23. Using Epigenetic Tools to Investigate Antidepressant Response.
Fiori LM; Lin R; Ju C; Belzeaux R; Turecki G
Prog Mol Biol Transl Sci; 2018; 158():255-272. PubMed ID: 30072056
[TBL] [Abstract][Full Text] [Related]
24. Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression.
Montano CB; Jackson WC; Vanacore D; Weisler R
Postgrad Med; 2023 Jun; 135(5):449-465. PubMed ID: 36912037
[TBL] [Abstract][Full Text] [Related]
25. An epigenome-wide methylation study of healthy individuals with or without depressive symptoms.
Shimada M; Otowa T; Miyagawa T; Umekage T; Kawamura Y; Bundo M; Iwamoto K; Ikegame T; Tochigi M; Kasai K; Kaiya H; Tanii H; Okazaki Y; Tokunaga K; Sasaki T
J Hum Genet; 2018 Mar; 63(3):319-326. PubMed ID: 29305581
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial.
Engelmann J; Zillich L; Frank J; Wagner S; Cetin M; Herzog DP; Müller MB; Tadic A; Foo JC; Sirignano L; Braus DF; Dahmen N; Sordon S; Riemenschneider M; Spaniol C; Gasparoni G; Rietschel M; Witt SH; Lieb K; Streit F
Transl Psychiatry; 2022 Jul; 12(1):268. PubMed ID: 35794104
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic alterations in depression and antidepressant treatment.
Menke A; Binder EB
Dialogues Clin Neurosci; 2014 Sep; 16(3):395-404. PubMed ID: 25364288
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers predicting antidepressant treatment response: how can we advance the field?
Labermaier C; Masana M; Müller MB
Dis Markers; 2013; 35(1):23-31. PubMed ID: 24167346
[TBL] [Abstract][Full Text] [Related]
29. Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.
Domschke K; Tidow N; Schwarte K; Ziegler C; Lesch KP; Deckert J; Arolt V; Zwanzger P; Baune BT
J Neural Transm (Vienna); 2015 Jan; 122(1):99-108. PubMed ID: 24809685
[TBL] [Abstract][Full Text] [Related]
30. Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment.
Fuh SC; Fiori LM; Turecki G; Nagy C; Li Y
PLoS One; 2023; 18(5):e0285123. PubMed ID: 37186582
[TBL] [Abstract][Full Text] [Related]
31. FKBP5 DNA methylation does not mediate the association between childhood maltreatment and depression symptom severity in the Detroit Neighborhood Health Study.
Bustamante AC; Aiello AE; Guffanti G; Galea S; Wildman DE; Uddin M
J Psychiatr Res; 2018 Jan; 96():39-48. PubMed ID: 28961425
[TBL] [Abstract][Full Text] [Related]
32. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.
Tansey KE; Rucker JJ; Kavanagh DH; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans DM; Hauser J; Henigsberg N; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Lewis G; Kapur S; McGuffin P; Uher R
Pharmacogenomics J; 2014 Aug; 14(4):395-9. PubMed ID: 24445990
[TBL] [Abstract][Full Text] [Related]
33. Influence and interaction of resting state functional magnetic resonance and tryptophan hydroxylase-2 methylation on short-term antidepressant drug response.
Tan T; Xu Z; Gao C; Shen T; Li L; Chen Z; Chen L; Xu M; Chen B; Liu J; Zhang Z; Yuan Y
BMC Psychiatry; 2022 Mar; 22(1):218. PubMed ID: 35337298
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models.
Chistiakov DA; Bobryshev YV; Chekhonin VP
Curr Pharm Des; 2017; 23(44):6828-6840. PubMed ID: 29086676
[TBL] [Abstract][Full Text] [Related]
35. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression.
Meylan EM; Halfon O; Magistretti PJ; Cardinaux JR
Neuropharmacology; 2016 Aug; 107():111-121. PubMed ID: 26970016
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Alterations and Prenatal Maternal Depression.
Nemoda Z; Szyf M
Birth Defects Res; 2017 Jul; 109(12):888-897. PubMed ID: 28714605
[TBL] [Abstract][Full Text] [Related]
37. Gene × environment interactions in the prediction of response to antidepressant treatment.
Klengel T; Binder EB
Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
[TBL] [Abstract][Full Text] [Related]
38. The relationship of tryptophan hydroxylase-2 methylation to early-life stress and its impact on short-term antidepressant treatment response.
Shen T; Li X; Chen L; Chen Z; Tan T; Hua T; Chen B; Yuan Y; Zhang Z; Kuney L; Xu Z
J Affect Disord; 2020 Nov; 276():850-858. PubMed ID: 32738671
[TBL] [Abstract][Full Text] [Related]
39. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic mechanisms of depression and antidepressant action.
Vialou V; Feng J; Robison AJ; Nestler EJ
Annu Rev Pharmacol Toxicol; 2013; 53():59-87. PubMed ID: 23020296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
